A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

County-level breast, cervical, and colorectal cancer screening in the US rose from 1997 to 2019, but persistently high- and low-screening clusters remained in the Northeast and Southwest, a study ...

BERLIN — Pairing a screening or surveillance colonoscopy with a same-day esophagogastroduodenoscopy (EGD) proved feasible and yielded clinically relevant upper gastrointestinal (GI) findings, ...

The markets are about to see just how robust the fervor is for artificial intelligence. Cloud-computing provider CoreWeave is set to start trading this morning. It raised $1.5 billion Thursday in a ...

Background Early recognition and accurate diagnosis are particularly important in the context of gastric cancer. This study mainly aimed to investigate primary care physicians’ (PCPs’) clinical ...

Thought LeadersAndrea DoolanCEO and co-founderAtlantia Food Clinical Trials In this interview, Andrea Doolan, CEO and co-founder of Atlantia Clinical Trials, describes a case study trial on ...

Endoscopy prep—getting ready for a colonoscopy or upper GI endoscopy—can be intimidating and a bit nerve-racking. During an endoscopy, doctors use a tiny camera to look inside your body, so it’s ...

The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer. The FDA’s approval was based on findings ...

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...